Literature DB >> 12121015

Is hyperventilation-induced nystagmus more common in retrocochlear vestibular disease than in end-organ vestibular disease?

Jeffrey Robichaud1, Heather DesRoches, Manohar Bance.   

Abstract

Hyperventilation-induced nystagmus (HVIN) has previously been shown by the senior author to be common in patients with both acoustic neuromas and following resection. The recurrent study's aim was to examine if HVIN was specific for retrocochlear pathology. To test this, the incidence of HVIN in 24 patients with confirmed acoustic neuroma was compared with its incidence in 38 patients with end-organ vestibular disease (defined as a greater than 25% reduction in caloric testing). Hyperventilation was carried out for 90 seconds. The results showed that 58% of the acoustic neuroma group were positive for HVIN versus 18% of the end-organ group. This difference was very significant on chi-square testing (p < .002). Hyperventilation-induced nystagmus appears to be much more prevalent in retrocochlear pathology than in end-organ pathology.

Entities:  

Mesh:

Year:  2002        PMID: 12121015     DOI: 10.2310/7070.2002.10796

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  4 in total

Review 1.  Tests used to evaluate dizziness in primary care.

Authors:  Jacquelien Dros; Otto R Maarsingh; Henriëtte E van der Horst; Patrick J Bindels; Gerben Ter Riet; Henk C van Weert
Journal:  CMAJ       Date:  2010-07-19       Impact factor: 8.262

Review 2.  Bedside evaluation of dizzy patients.

Authors:  Young-Eun Huh; Ji-Soo Kim
Journal:  J Clin Neurol       Date:  2013-10-31       Impact factor: 3.077

3.  Hyperventilation-induced nystagmus in vestibular schwannoma and unilateral sensorineural hearing loss.

Authors:  Marco Mandalà; Annalisa Giannuzzi; Serena Astore; Franco Trabalzini; Daniele Nuti
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-30       Impact factor: 2.503

4.  Hyperventilation-induced nystagmus in a large series of vestibular patients.

Authors:  L Califano; M G Melillo; A Vassallo; S Mazzone
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-02       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.